By Morgane Rousselot (SeaBeLife)2024-07-03T10:00:14
We had the privilege of speaking to Morgane Rousselot, co-founder and CEO of SeaBeLife for our Women in Stem series. With a strong scientific background and over two decades of entrepreneurial experience in the biotechnology field, she leads the company with a team-focused approach and intellectual rigor.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-08-28T10:00:24Z
2024-03-08T10:00:25
Sponsored by Molecular Devices
2024-02-02T15:48:26
Sponsored by Bio-Techne
2023-07-11T16:13:06
Sponsored by Agilent
2023-02-07T15:25:20
Sponsored by Bio-Techne
2023-03-20T13:41:33
Sponsored by Bio-Techne
2023-03-23T14:46:21
Sponsored by Bio-Techne
Site powered by Webvision Cloud